No Data
Akatsuki Sees FY Net Y2.60B
Akatsuki: Notice regarding revisions to full-year consolidated earnings forecasts and revisions to dividend forecasts (dividend increases) for the fiscal year ending March 31, 2025
Akatsuki: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)
Japan Post, Kampo Life Insurance, Japan Post Bank, Tokio Marine (14th) (5571-9989)
The above Calendar is just a schedule and is subject to change due to company circumstances. --------------------------------------- February 14 (Friday) <5571> Excite HD <5582> Grid <5587> Inbound PF <5588> First A <5590> Net Stars <5591> AVILEN <5592> Kusuri no Madoguchi <5616> Rain and Wind and Sun <56
Express News | [Change Report] Old Peak reports an increase in the Shareholding of Akatsuki Headquarters (8737.JP) to 8.8%.
Helios --- fell back, entered into a joint business agreement and a Single Option license agreement with Akatsuki.
It fell back. It was announced that a joint business contract and a Single Option license agreement were concluded with Akatsuki, a 100% owned subsidiary, to promote research and development of next-generation cancer immunotherapy using eNK cells. Although it started rising, the upper price was heavy. Moving forward, Akatsuki will lead the research and development operations for eNK cells that have been conducted independently, and the company will be commissioned by Akatsuki. This is expected to reduce the burden of research and development funding, with initial commissioning from Akatsuki anticipated by February 2025.